Methicillin-Resistant Staphylococcus Aureus (MRSA), is a strain of Staphylococcus Aureaus resistant to a large group of antibiotics called the beta-lactams, including penicillin. It is a majour cause of hospital aquired infections which are difficult to treat. Resistance to the beta-lactam class of antibiotics in MRSA is mediated by Penicillin Binding Protein 2a (PBP2a) a bacterial cell wall protein, encoded by the mecA gene.
Scipac supply highly specific mouse monoclona antibodies for MRSA PBP2a detection. These antibodies have been shown to work in ELISA as well as Western Blot format, and detect MRSA with minimal cross reactivity to MSSA.